Knowledge Centre

The UK BioIndustry Association has established a Vaccines Manufacturing Taskforce in response to Covid-19.

KTN hosted two Health Investment Showcases in April with organisations from the health sector pitching for investment.

LifeArc & MRC are making £16m available to establish Gene Therapy Innovation Hubs.

At KTN many sectors our experts operate in are playing a part in facilitating social distancing.

An update from Gary Cutts, Challenge Director, on this four year Industrial Strategy Challenge Fund Challenge.

As it is the new year, the phase 1 invitations have been issued and I am officially now the permanent Challenge Director, I felt a New Year blog was in order. I will do this every 3rd or 4th month to “chat” about the Future Flight Challenge more broadly.

KTN uses deep sector expertise to make powerful connections across sectors, geographies and skill-sets to drive change through innovation.

£9.5m available from UK Research and Innovation (UKRI) to support world leading research into healthy ageing solutions.

KTN and the Biopharmaceutical Formulation Group hosted a webinar on 7th July on ‘Formulation challenges for delivery of RNA therapies’.

Five organisations have received funding from the Sellafield Game Changers programme after they were selected following a challenge process run by KTN.

On the 4 May 2020, KTN hosted a webinar to present findings following an Agri-Tech Global Expert Mission to Australia.